ActTrader voted as the ‘The Best Multi-Asset Platform’ at The Forex Expo, Dubai 2021
ActTrader, now a Finvasia Group Company, won this year’s best Multi-Asset Platform award at largest trading event in the MENA region - The Forex Expo, Dubai 2021. The award recognises businesses that push the boundaries of innovation in the Fintech space.
ActTrader provides customised solutions and dedicated technical infrastructure to some of the biggest forex brokers, hedge funds, ECN venues, multi-asset exchanges and financial institutions. They offer adaptive trading technology that works seamlessly through a single feature-rich application, eliminating the need of integrating with third-party applications.
When contacted, Sarvjeet Singh, co-founder Finvasia said he feels humbled to have achieved this milestone within the first year of their acquisition of ActTrader. "We envisage to build innovative technology solutions that meet the evolving needs of current and future needs of financial institutions," he further added.
The Fore Expo is one of the biggest trading event that hosts prestigious brokers, technology providers, financial institutions, banks, retail traders and media houses from the financial services industry. With more than 7000 in attendance, it is a place for people from the finance industry to coming together in one place.
"ActTrader has been making a buzz ever since its inception in 2000. It has helped thousands of multi-asset brokers and financial institutions globally to revolutionise their trading operations, hedge their risk, and yield profits with its tailor-made solutions." - Ilya Sorokin, Founder & CEO, ActTrader.
About ActTrader
ActTrader is a leading provider of multi-asset trading technologies with award-winning products including the state-of-the-art trading platform, order execution engine, CRM solutions, Auto Trading Algorithms, White Label Solutions, STP Liquidity through FIX API, Multi-platform bridge, AI-based social trading, crypto exchange, and other value-added services.
To expand the company’s B2B offerings, ActTrader joined forces with Finvasia Group- a multinational organisation that owns various brands in the financial services, healthcare, real estate, blockchain, and technology sectors.
Know more: https://acttrader.com/
About FINVASIA Group
FINVASIA is a multi-disciplinary, multinational organisation registered with regulatory bodies across the world, via its subsidiaries and sister concerns, in various capacities including SEC, USA (152771), CYSEC (367/18), FCA (850138), BaFin (157125), ACPR (85051), CONSOB (5151), CNVM (4892), Finanstilsynet (FT00118545) and more.
In India, Finvasia is registered with the Reserve Bank of India as an NBFC, NSE as a Professional Clearing member (M51912), BSE (4043), MCX (55135), and NCDEX as Trading Member (01259), AMFI (103331) and CDSL as Depository Participant (12084300).
Know more: https://finvasia.com/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211102005647/en/
Contact information
Media Contact
Ms. Sandeep Samra
media@stackflow.org
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Echoworx Secures FSQS-Netherlands Certification, Strengthening Trust in Financial Data Protection16.12.2025 08:00:00 EET | Press release
Echoworx, a global leader in email and data encryption, proudly announces it has achieved Financial Services Qualification System (FSQS) registered supplier status for the Netherlands. This certification powerfully demonstrates Echoworx’s commitment to the highest standards of security and compliance. This achievement expands on the company’s existing FSQS certification for the UK and Ireland, secured in 2020. By successfully completing the rigorous qualification for the Netherlands, Echoworx reinforces its alignment with the stringent demands of the European financial market. The FSQS system, managed by Hellios, provides a single, reliable standard for vetting third-party suppliers, streamlining procurement for major banks and financial institutions. Think of FSQS as a high-security passport for technology partners. It proves a supplier has undergone an exhaustive audit of its governance, security controls, and operational processes. For Dutch financial institutions, this qualificatio
Nippon Electric Glass to Start World’s First Mass Production of Low-Carbon Pharmaceutical Glass Tubing Using an All-Electric Furnace16.12.2025 04:00:00 EET | Press release
Nippon Electric Glass Co., Ltd. (NEG)(TOKYO:5214), a global leader in specialty glass headquartered in Otsu, Japan, announced it will begin the world’s first mass production of pharmaceutical-grade glass tubing using an all-electric melting furnace. Commercial production is scheduled to start in December 2025 at its subsidiary in Selangor, Malaysia. This breakthrough introduces a new manufacturing model for pharmaceutical packaging. By combining NEG’s proprietary all-electric melting technology with renewable energy, CO2 emissions from glass tubing production can be reduced by up to 90%*1 compared with conventional fossil-fuel combustion furnaces. This positions NEG as a major supplier capable of delivering both high-performance borosilicate glass and a significantly lower carbon footprint, directly addressing global sustainability demands from pharmaceutical companies and regulators. NEG is a leading global supplier of arsenic-free, environmentally friendly borosilicate glass tubing f
Esco Aster Signs Exosome Clinical cGMP Manufacturing Contract With Shine-On Biomedical For A Novel First-In-Class HLA-G Targeting Exosome Drug Delivery Platform16.12.2025 03:00:00 EET | Press release
Esco Aster, a vertically integrated cell and derivatives CRDMO based at JTC LaunchPad Singapore, announced CMC manufacturing support for Shine-On Biomedical’s HLA-G targeted exosome program. Shine-On Biomedical sponsored Esco Aster in 2023 for cGMP services, starting with high-yield exosome development using Esco Aster’s cell line platform. The technical reports of process, analytical, and formulation development, exosome drug loading, GMP engineering runs, and stability studies supported Shine-On’s IND submission. The IND was cleared by the U.S. FDA in Q1 2025. Furthermore, Esco Aster is providing technical services for exploratory exosome loading feasibility studies per Shine-On’s instruction. Shine-On Biomedical is an emerging innovator in exosome-based drug delivery. ShineOn’s proprietary product, SOB100, a HLA-G targeted exosome drug delivery carrier, has passed the U.S. FDA IND review and ongoing Phase I study, making it as a first-in-class–potential HLA-G targeted exosome platfo
Civil Air Patrol Expands Fleet With 15 New Cessna Aircraft to Support Lifesaving and Community Missions15.12.2025 18:00:00 EET | Press release
Textron Aviation Inc., a Textron Inc. (NYSE: TXT) company, announced today that Civil Air Patrol (CAP), the world’s largest operator of Cessna aircraft, is strengthening its national mission capabilities with an order for 15 additional piston-engine aircraft, including seven Cessna Skyhawk 172 and eight Cessna Skylane 182 models scheduled for delivery throughout 2026. The order follows recent deliveries of an additional two Cessna Skylane and one Cessna Turbo Stationair HD aircraft, expanding CAP’s fleet to more than 500 Cessna aircraft nationwide. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215613573/en/ Delivery of an additional two Cessna Skylane and one Cessna Turbo Stationair HD aircraft joins CAP’s fleet of more than 500 Cessna aircraft nationwide. Cessna aircraft are designed and produced by Textron Aviation. “Civil Air Patrol’s missions demand aircraft that are reliable, versatile and ready to perform in critic
Winston & Strawn and Taylor Wessing UK to Combine, Creating a Premier Transatlantic Law Firm15.12.2025 17:52:00 EET | Press release
Winston & Strawn and Taylor Wessing’s UK-led business announced today their intention to combine, creating a premier transatlantic law firm that would operate under a new shared name, Winston Taylor. The combination responds to increasing client demand for seamlessly integrated US–UK–EU counsel for the businesses, people, and markets driving capital and innovation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215914957/en/ The combination once final will unite two international firms with more than 400 years of combined history, complementary strengths, and a common vision to meet clients’ evolving global needs. The combined firm will include more than 1,400 lawyers, establishing one of the largest transatlantic firms whose footprint is primarily in the United States, the United Kingdom, and Europe, and also in Latin America and the Middle East. Leveraging significant strength and scale in major litigation, critical tra
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom